ES8609364A1 - Procedimiento de preparar derivados antihipertensivos - Google Patents

Procedimiento de preparar derivados antihipertensivos

Info

Publication number
ES8609364A1
ES8609364A1 ES546866A ES546866A ES8609364A1 ES 8609364 A1 ES8609364 A1 ES 8609364A1 ES 546866 A ES546866 A ES 546866A ES 546866 A ES546866 A ES 546866A ES 8609364 A1 ES8609364 A1 ES 8609364A1
Authority
ES
Spain
Prior art keywords
antihypertensive
derivatives
substituents
chem
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES546866A
Other languages
English (en)
Other versions
ES546866A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pharmaceutical Corp
Original Assignee
USV Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/649,797 external-priority patent/US4746676A/en
Priority claimed from US06/752,695 external-priority patent/US4749698A/en
Application filed by USV Pharmaceutical Corp filed Critical USV Pharmaceutical Corp
Publication of ES546866A0 publication Critical patent/ES546866A0/es
Publication of ES8609364A1 publication Critical patent/ES8609364A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

OBTENCION DE DERIVADOS ANTIHIPERTENSIVOS Y MAS PARTICULARMENTE, DE COMPUESTOS DE FORMULA (I) Y SUS SALES DE ADICION DE ACIDO, DE METALES ALCALINOS Y ALCALINOTERREOS FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN ACOPLAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), BAJO CONDICIONES DE FORMACION DE PEPTIDOS, OBTENIENDOSE COMO COMPUESTO FINAL UNA SAL DEL PRODUCTO. SE UTILIZAN EN PREPARACIONES PARA ADMINISTRACION ORAL O PARENTERAL, PARA REDUCIR LA HIPERTENSION, PROMOVIENDO LA DIURESIS.
ES546866A 1984-09-12 1985-09-11 Procedimiento de preparar derivados antihipertensivos Expired ES8609364A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/649,797 US4746676A (en) 1984-09-12 1984-09-12 Carboxyalkyl dipeptide compounds
US06/752,695 US4749698A (en) 1985-07-08 1985-07-08 Antihypertensive derivatives

Publications (2)

Publication Number Publication Date
ES546866A0 ES546866A0 (es) 1986-07-16
ES8609364A1 true ES8609364A1 (es) 1986-07-16

Family

ID=27095707

Family Applications (1)

Application Number Title Priority Date Filing Date
ES546866A Expired ES8609364A1 (es) 1984-09-12 1985-09-11 Procedimiento de preparar derivados antihipertensivos

Country Status (13)

Country Link
EP (1) EP0175266B1 (es)
KR (1) KR860002464A (es)
AT (1) ATE135711T1 (es)
AU (1) AU578489B2 (es)
CA (1) CA1288893C (es)
DE (1) DE3588094T2 (es)
DK (1) DK412985A (es)
ES (1) ES8609364A1 (es)
FI (1) FI89716C (es)
IL (1) IL76345A (es)
IN (1) IN164615B (es)
NO (1) NO169442C (es)
NZ (1) NZ213432A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
WO1995034577A1 (en) * 1994-06-16 1995-12-21 Smithkline Beecham Corporation Template directed cyclization
ATE324876T1 (de) † 1999-10-14 2006-06-15 Curis Inc VERMITTLER VON ßHEDGEHOGß ÜBERMITTELNDEN BAHNEN, DAZUGEHÖRIGE ZUSAMMENETZUNGEN UND VERWENDUNGEN
DE50015940D1 (de) 2000-09-21 2010-07-29 Abb Schweiz Ag Konfiguration eines Leitsystems einer elektrischen Schaltanlage
WO2007078990A2 (en) * 2005-12-23 2007-07-12 Zealand Pharma A/S Modified lysine-mimetic compounds
EP2074087A2 (en) 2006-12-21 2009-07-01 Wyeth Synthesis of pyrrolidine compounds
CN110709096B (zh) 2017-05-05 2023-10-31 泽兰德制药公司 细胞间隙连接通讯调节剂及其在糖尿病性眼病治疗中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5683483A (en) * 1979-12-13 1981-07-08 Santen Pharmaceut Co Ltd Thiazolidine compound
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
EP0048159A3 (en) * 1980-09-17 1982-05-12 University Of Miami Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents
US4462943A (en) * 1980-11-24 1984-07-31 E. R. Squibb & Sons, Inc. Carboxyalkyl amino acid derivatives of various substituted prolines
FR2501399B1 (fr) * 1981-03-03 1987-06-19 France Etat Dispositif d'affichage de messages graphiques transmis par des systemes de videotex
EP0080822A1 (en) * 1981-11-27 1983-06-08 Beecham Group Plc Anti-hypertensive prolinol-based peptides
EP0088350B1 (en) * 1982-03-08 1985-02-20 Schering Corporation Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
ZA832762B (en) * 1982-04-30 1983-12-28 Squibb & Sons Inc Substituted 4-phenoxy prolines
IL69136A0 (en) * 1982-07-19 1983-10-31 Squibb & Sons Inc Substituted peptide compounds
US4623729A (en) * 1982-07-22 1986-11-18 E. R. Squibb & Sons, Inc. Acylalkylaminocarbonyl substituted amino and imino acid compounds
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
FI841052A (fi) * 1983-03-16 1984-09-17 Usv Pharma Corp Foereningar foer behandling av blodtryckssjukdomar.
EP0127124A3 (en) * 1983-05-23 1987-04-08 Usv Pharmaceutical Corporation Compounds for treating hypertension

Also Published As

Publication number Publication date
ATE135711T1 (de) 1996-04-15
CA1288893C (en) 1991-09-10
NO853551L (no) 1986-03-13
KR860002464A (ko) 1986-04-26
DK412985D0 (da) 1985-09-11
NO169442C (no) 1992-06-24
DK412985A (da) 1986-03-13
DE3588094D1 (de) 1996-04-25
IN164615B (es) 1989-04-22
FI89716C (fi) 1993-11-10
FI853494L (fi) 1986-03-13
EP0175266A2 (en) 1986-03-26
AU4733185A (en) 1986-03-20
FI89716B (fi) 1993-07-30
NZ213432A (en) 1988-11-29
ES546866A0 (es) 1986-07-16
AU578489B2 (en) 1988-10-27
FI853494A0 (fi) 1985-09-12
EP0175266A3 (en) 1988-08-03
IL76345A0 (en) 1986-01-31
EP0175266B1 (en) 1996-03-20
NO169442B (no) 1992-03-16
IL76345A (en) 1988-12-30
DE3588094T2 (de) 1996-08-22

Similar Documents

Publication Publication Date Title
ATE75743T1 (de) Hydrazinderivate und ihre verwendung.
CA1271747C (en) BENZAZEPINE DERIVATIVES
ES8609364A1 (es) Procedimiento de preparar derivados antihipertensivos
ZA872825B (en) New pyrimidine derivatives,having fungicidal activity
ES8602631A1 (es) Procedimiento de producir compuestos para tratar la hipertension
ES8602021A1 (es) Procedimiento de preparar compuestos espirociclicos antihi- pertensivos
CA1271748C (en) BENZAZEPINE DERIVATIVES
AU577140B2 (en) 2,4-diamino-6-difluoromethylthio-1,3,5-triazine derivatives
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
CA1265131C (en) ERYTHROMYCYLAMINE DERIVATIVES
DE3586745T2 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
ES8606874A1 (es) Metodo de preparacion de compuestos espiroamidoamino anti- hipertensivos
EP0127090A3 (en) Angiotensin-converting enzyme inhibitors
EP0153755A3 (en) Compounds for treating hypertension
GR852224B (es)
AU4004085A (en) 3-mercapto-1,2,4-triazacycloalkadiene derivatives
MY102050A (en) Imidazole anologs of mevalonolactone and derivatives thereof
SU1132513A1 (ru) 2-метиламино-4-оксо-3,6,6-триметил-5,6-дигидро-8н-пирано[4′,3′ : 4,5]тиено[2,3-d]пиримидин или его соли, обладающие противосудорожной активностью
IT8433319V0 (it) Spiralex maxima securitas 2000 n. 5cu 285,70 mg
SU1610823A1 (ru) S-трет-бутилтиуронийбромид, обладающий антиишемической активностью
UA11675A1 (uk) 1-БЕtА-ОКСИЕТИЛАМІHО-3-КЕТО-5,5-ДИМЕТИЛЦИКЛОГЕКСЕH -1, ЯКИЙ МАЄ АHАЛЬГЕТИЧHУ АКТИВHІСТЬ
NO892693L (no) Fremgangsmaate for fremstilling av 1-substituert-aryl-1, 4-dihydro-4-iksonaftyridin-derivater.
SU1116706A1 (ru) Производные 2,3,4,5-тетрагидро-1н-1,5-бензодиазепинона-2, проявляющие противовоспалительную активность
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью
DE3568161D1 (de) 15(r+s)-fluorine-11,15-didesoxyprostaglandin e 1? derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19981001